ArticleBlood cancer journal2023

Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study.

Sohee Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.